Newsletters

Sanofi’s in-house DTx. 1,162 clinical trials used digital tools in 2018.

12.06.19

5 min. Read

Proteus headcount dip. Smart pill standards.

11.22.19

6 min. Read

Google-Ascension recap. Deals, clearances, studies.

11.15.19

5 min. Read

FDA sleeps on AI/ML guidance. Google buys Fitbit for $2.1B

11.01.19

8 min. Read

Scoop: Stealthy OSA acquisition. Fake DTx unicorn?

10.25.19

5 min. Read

Pear-Sandoz’s conscious uncoupling. W. Virgina wants DTx.

10.18.19

7 min. Read

Roche-Genentech to develop in-house digital therapeutic. UHC. Livongo.

10.11.19

6 min. Read

Building digital therapeutics studies for the FDA vs. payers

10.04.19

15 min. Read

Senate bill mentions DTx. Pear lobbying. FDA vs payers.

10.04.19

6 min. Read

Trouble in Pear-adise? More details on ESI’s digital formulary.

9.27.19

8 min. Read